|Articles|March 28, 2011

HIT Press Club AJMC - Amol Navathe, MD, PhD

Dr. Amol Navathe, US Dept of Health and Human Services

Dr. Amol Navathe, MD, PhD, US Dept of Health and Human Services, discusses his paper and answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related to this article

October 29th, 2026

Closing the Gap From HCV Diagnosis to Cure: Norah Terrault, MD, MPH

Norah Terrault, MD, MPH, on why few diagnosed patients reach HCV cure and how primary care test-and-treat can close the gap.

HIT Press Club AJMC - Amol Navathe, MD, PhD

Related to this article

Trending on AJMC

First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy

Unanswered Questions in First- and Second-Line mCRC Care

Multidisciplinary Care for Vitiligo: Beyond Dermatology

Planning for Third-Line Therapy and Treatment Rechallenge in mCRC

Precision Drugs Meet Payer Realities

Delivering Cellular Therapy in Community Oncology: OHC’s Approach

HIT Press Club AJMC - Amol Navathe, MD, PhD

Related to this article

Trending on AJMC

First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy

Unanswered Questions in First- and Second-Line mCRC Care

Multidisciplinary Care for Vitiligo: Beyond Dermatology

Planning for Third-Line Therapy and Treatment Rechallenge in mCRC

Precision Drugs Meet Payer Realities